ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 84 filers reported holding ADICET BIO INC in Q3 2023. The put-call ratio across all filers is 7.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $186,317 | +7.9% | 135,998 | +91.4% | 0.00% | – |
| Q2 2023 | $172,690 | +806.9% | 71,066 | +2049.6% | 0.00% | – |
| Q1 2023 | $19,042 | -99.6% | 3,306 | -99.4% | 0.00% | -100.0% |
| Q4 2022 | $5,037,985 | -56.2% | 563,533 | -30.4% | 0.00% | 0.0% |
| Q3 2022 | $11,509,000 | -2.6% | 809,351 | +0.0% | 0.00% | 0.0% |
| Q2 2022 | $11,813,000 | +4.0% | 809,129 | +42.3% | 0.00% | 0.0% |
| Q1 2022 | $11,354,000 | +146.1% | 568,566 | +115.6% | 0.00% | – |
| Q4 2021 | $4,613,000 | – | 263,765 | +941917.9% | 0.00% | – |
| Q4 2020 | $0 | – | 28 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 1,615,385 | $20,968,000 | 7.24% |
| Consonance Capital Management LP | 1,216,860 | $15,917,000 | 1.70% |
| VR Adviser, LLC | 1,000,000 | $13,080,000 | 1.42% |
| Johnson & Johnson Innovation - JJDC, Inc. | 728,944 | $9,535,000 | 1.24% |
| DAFNA Capital Management LLC | 385,077 | $5,037,000 | 1.20% |
| Ally Bridge Group (NY) LLC | 425,000 | $5,559,000 | 1.07% |
| Orbimed Advisors | 7,232,856 | $94,606,000 | 0.88% |
| Avidity Partners Management LP | 2,230,000 | $29,168,000 | 0.81% |
| Altium Capital Management LP | 142,289 | $1,861,000 | 0.52% |
| Nantahala Capital Management | 395,875 | $5,178,000 | 0.15% |